Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 4 of 56
Includes a footnote regarding a 1-for-25 reverse stock split.
Pitch deck · appendix_data · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
disclaimer 1/1 list 1/1 paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 6
disclaimer bullet paragraph source-note valuation headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.